Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Godson

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 20, 2019
Unravelling the transcriptional responses of TGF-β: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specificationDarrell Andrews, Giorgio Oliviero, Letizia De Chiara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2024
The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast-Monocyte InteractionsCarlos Matellan, Ciarán Kennedy, Miren Itxaso Santiago-Vela, et al.
BMJ Open Diabetes Research & Care|August 5, 2020
Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney diseaseMeera Nair, William P Martin, Vadim Zhernovkov, et al.
Biochimica Et Biophysica Acta|April 10, 2013
IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responsesJames B Corcoran, Sarah McCarthy, Brenda Griffin, et al.
Journal of the American Society of Nephrology : JASN|May 30, 2008
IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosisMadeline Murphy, Neil G Docherty, Brenda Griffin, et al.
Frontiers in Endocrinology|February 28, 2022
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney DiseaseWilliam P Martin, Yeong H D Chuah, Mahmoud Abdelaal, et al.
BMC Genomics|June 10, 2024
Genetic variants affecting mitochondrial function provide further insights for kidney diseaseMarisa Cañadas-Garre, Blanca Baños-Jaime, Joaquín J Maqueda, et al.
Pharmacological Research|January 25, 2021
Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammationIzabela Galvão, Eliza M Melo, Vivian L S de Oliveira, et al.
Epigenetics|May 12, 2010
DNA methylation profiling in cell models of diabetic nephropathyEoin P Brennan, Mathias Ehrich, Helen O'Donovan, et al.
Kidney International|November 25, 2003
DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transitionDebra F Higgins, David W P Lappin, Niamh E Kieran, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 20, 2019
Unravelling the transcriptional responses of TGF-β: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specificationDarrell Andrews, Giorgio Oliviero, Letizia De Chiara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2024
The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast-Monocyte InteractionsCarlos Matellan, Ciarán Kennedy, Miren Itxaso Santiago-Vela, et al.
BMJ Open Diabetes Research & Care|August 5, 2020
Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney diseaseMeera Nair, William P Martin, Vadim Zhernovkov, et al.
Biochimica Et Biophysica Acta|April 10, 2013
IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responsesJames B Corcoran, Sarah McCarthy, Brenda Griffin, et al.
Journal of the American Society of Nephrology : JASN|May 30, 2008
IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosisMadeline Murphy, Neil G Docherty, Brenda Griffin, et al.
Frontiers in Endocrinology|February 28, 2022
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney DiseaseWilliam P Martin, Yeong H D Chuah, Mahmoud Abdelaal, et al.
BMC Genomics|June 10, 2024
Genetic variants affecting mitochondrial function provide further insights for kidney diseaseMarisa Cañadas-Garre, Blanca Baños-Jaime, Joaquín J Maqueda, et al.
Pharmacological Research|January 25, 2021
Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammationIzabela Galvão, Eliza M Melo, Vivian L S de Oliveira, et al.
Epigenetics|May 12, 2010
DNA methylation profiling in cell models of diabetic nephropathyEoin P Brennan, Mathias Ehrich, Helen O'Donovan, et al.
Kidney International|November 25, 2003
DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transitionDebra F Higgins, David W P Lappin, Niamh E Kieran, et al.
Pageof 14